These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 17473379)
1. Effect of polaprezinc on taste disorders in zinc-deficient rats. Hamano H; Yoshinaga K; Eta R; Emori Y; Kawasaki D; Iino Y; Sawada M; Kuroda H; Takei M Biofactors; 2006; 28(3-4):185-93. PubMed ID: 17473379 [TBL] [Abstract][Full Text] [Related]
2. Effects of polaprezinc on morphological change of the tongue in zinc-deficient rats. Kinomoto T; Sawada M; Ohnishi Y; Yamaguchi T; Tsuge S; Ogawa S; Washizuka M; Minaguchi J; Mera Y; Takehana K J Oral Pathol Med; 2010 Sep; 39(8):617-23. PubMed ID: 21054547 [TBL] [Abstract][Full Text] [Related]
3. [Development of polaprezinc research]. Takei M Yakugaku Zasshi; 2012; 132(3):271-7. PubMed ID: 22382829 [TBL] [Abstract][Full Text] [Related]
4. Polaprezinc, a zinc compound, is distributed to the lingual epithelium and increases its zinc concentration in zinc-deficient rats. Hamano H; Yoshinaga K; Tanaka T; Eta R; Horii T; Kawabata Y; Furuta S; Takei M Life Sci; 2009 Nov; 85(21-22):759-64. PubMed ID: 19846043 [TBL] [Abstract][Full Text] [Related]
5. [The Effectiveness of Polaprezinc Preparation for Taste Alteration in Cancer Chemotherapy]. Mizukami Y; Sato J; Nihei S; Kashiwaba M; Kudo K; Okuyama H; Tamura K Gan To Kagaku Ryoho; 2016 Aug; 43(8):979-83. PubMed ID: 27539040 [TBL] [Abstract][Full Text] [Related]
6. A zinc-containing compound, Polaprezinc, is effective for patients with taste disorders: randomized, double-blind, placebo-controlled, multi-center study. Sakagami M; Ikeda M; Tomita H; Ikui A; Aiba T; Takeda N; Inokuchi A; Kurono Y; Nakashima M; Shibasaki Y; Yotsuya O Acta Otolaryngol; 2009 Oct; 129(10):1115-20. PubMed ID: 19037756 [TBL] [Abstract][Full Text] [Related]
8. Polaprezinc (Zinc-L-Carnosine Complex) as an Add-on Therapy for Binge Eating Disorder and Bulimia Nervosa, and the Possible Involvement of Zinc Deficiency in These Conditions: A Pilot Study. Sakae K; Suka M; Yanagisawa H J Clin Psychopharmacol; 2020; 40(6):599-606. PubMed ID: 33044355 [TBL] [Abstract][Full Text] [Related]
9. Residence time of polaprezinc (zinc L-carnosine complex) in the rat stomach and adhesiveness to ulcerous sites. Furuta S; Toyama S; Miwa M; Itabashi T; Sano H; Yoneta T Jpn J Pharmacol; 1995 Apr; 67(4):271-8. PubMed ID: 7650862 [TBL] [Abstract][Full Text] [Related]
10. Long-term zinc deficiency decreases taste sensitivity in rats. Goto T; Komai M; Suzuki H; Furukawa Y J Nutr; 2001 Feb; 131(2):305-10. PubMed ID: 11160551 [TBL] [Abstract][Full Text] [Related]
11. [Involvement of zinc in taste disturbance occurring during treatment for malignant tumor in the chest and the effects of polaprezinc oral disintegrating tablets (a retrospective study)]. Nakata Y; Hirashima T; Kondou Y; Tokuoka Y; Imazato H; Iwata K; Oomori Y; Yamato A; Shimizu S; Nagao S; Matsui K; Abe N Gan To Kagaku Ryoho; 2008 Jun; 35(6):955-9. PubMed ID: 18633224 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and Safety of Polaprezinc (Zinc Compound) on Zinc Deficiency: A Systematic Review and Dose-Response Meta-Analysis of Randomized Clinical Trials Using Individual Patient Data. Furihata K; Tsuchikawa M; Miwa T; Naito Y; Oba K; Sakagami M Nutrients; 2020 Apr; 12(4):. PubMed ID: 32316581 [TBL] [Abstract][Full Text] [Related]
13. Zinc deficiency and taste dysfunction; contribution of carbonic anhydrase, a zinc-metalloenzyme, to normal taste sensation. Komai M; Goto T; Suzuki H; Takeda T; Furukawa Y Biofactors; 2000; 12(1-4):65-70. PubMed ID: 11216508 [TBL] [Abstract][Full Text] [Related]
15. Ulcerogenic and healing impairing actions of monochloramine in rat stomachs: effects of zinc L-carnosine, polaprezinc. Nishiwaki H; Kato S; Sugamoto S; Umeda M; Morita H; Yoneta T; Takeuchi K J Physiol Pharmacol; 1999 Jun; 50(2):183-95. PubMed ID: 10424716 [TBL] [Abstract][Full Text] [Related]
16. Mucosal ulcerogenic action of monochloramine in rat stomachs: effects of polaprezinc and sucralfate. Kato S; Nishiwaki H; Konaka A; Takeuchi K Dig Dis Sci; 1997 Oct; 42(10):2156-63. PubMed ID: 9365151 [TBL] [Abstract][Full Text] [Related]
17. [Orally administered polaprezinc significantly improves taste disorders in ovarian cancer patient undergoing chemotherapy]. Nishijima S; Yanase T; Hata Y; Tamura R; Tsuneki I; Tamura M; Kurabayashi T Gan To Kagaku Ryoho; 2011 Apr; 38(4):689-92. PubMed ID: 21499007 [TBL] [Abstract][Full Text] [Related]
18. Zinc nutrition and salt preference in rats. Jakinovich W; Osborn DW Am J Physiol; 1981 Sep; 241(3):R233-9. PubMed ID: 7282969 [TBL] [Abstract][Full Text] [Related]
19. [Time course of changes in gustatory function test results and subjective symptoms, and predictive factors for response in patients with taste disorder receiving 24-week zinc replacement treatment]. Sakagami M; Kurono Y; Inokuchi A; Takeda N; Aiba T; Nin T; Ikeda M Nihon Jibiinkoka Gakkai Kaiho; 2014 Aug; 117(8):1093-101. PubMed ID: 25255648 [TBL] [Abstract][Full Text] [Related]
20. Effect of polaprezinc (N-(3-aminopropionyl)-L-histidinato zinc), a novel antiulcer agent containing zinc, on cellular proliferation: role of insulin-like growth factor I. Seto K; Yoneta T; Suda H; Tamaki H Biochem Pharmacol; 1999 Jul; 58(2):245-50. PubMed ID: 10423164 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]